On 13th June we commissioned our F1000 Specialists programme aimed at junior researchers who have a passion for scholarly communication. Today we celebrate our one-hundredth confirmed F1000 Specialist – congratulations to Vivek Misra. Vivek is a research fellow in the Department of Neurology, Voluntary Health Services Medical Centre, India and is a keen blogger. We have…
Jerome Korzelius, a new F1000 Specialist, guest posts on his experience at EMBO 2013. The EMBO Meeting 2013 was held in the vibrant city of Amsterdam. This annual event covered the breadth of the life sciences in Europe. With a more general focus, instead of concentrating on a single field, the meeting is ideal for…
Our F1000 Specialists programme continues to grow rapidly across the world. The most applications have been received from the USA, but a ground swell seems to be emerging in China with a number of applications and appointments in the region. Since the end of July, we have received more than 40 new applications in total…
At F1000, we are today announcing a new fully Open Access publishing program across biology and medicine, F1000 Research, which will launch later this year. It is intended to address the major issues afflicting scientific publishing today: timely dissemination of research, peer review, and sharing of data.
Once upon a time, I hated the very thought of living in London. since moving here, that attitude has changed completely. It’s not hard to see why: at some point, it seems, just about everyone and everything comes to this great city, either just passing through or to stay.
When you first fall in love, the passion can be intense, even burning. The object of affection is perfect in every way, they can do no wrong. After a while, that feeling begins to wear off. Maintaining interest and passion becomes hard work. It’s easier to criticize than to be complimentary.
The question in the title was prompted by a comment I received on a previous Naturally Selected blog post about the three deadly sins of grant writing. The commenter chose to pick on my grammar in the post, insinuating that because, in her opinion the post exhibited poor grammar, I wasn’t to be listened to.
The media faces constant criticism from medical specialists and advocacy groups whenever it trumpets the latest new wonder drug to cure any form of cancer. Many spurious claims have over the years been splashed across the UK Daily Mail’s front page, prompting backlash from organisations such as the National Health Service, Cancer Research UK and…
Sometimes there’s a real life-changing thrust to blog posts, that drives at the heart of a pivotal issue in modern society and make people question their motives, passions, opinions or even educational goals. But seeing as we’re all coming down off a post-Oscars high, let me preempt your own judgement by rating this one as…
We have previously discussed the honorable activities of the Americans for Medical Progress (AMP) and its members, including Dario Ringach whose recent paper on animal activism was highly rated by our reviewers. AMP send regular email updates to scientists and this item looked at an extremely important issue, so I am reproducing it here in…
